Question 1

What is Vedolizumab used for?

Accepted Answer

Vedolizumab (brand name Entyvio) is a Integrin Inhibitor indicated for Ulcerative Colitis, Crohn's Disease.

Question 2

How does Vedolizumab work?

Accepted Answer

Vedolizumab works through the following mechanism: Humanized monoclonal antibody that binds alpha4-beta7 integrin, blocking lymphocyte trafficking to gut-associated lymphoid tissue..

Question 3

What are the most common side effects of Vedolizumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Vedolizumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Vedolizumab the same as Entyvio?

Accepted Answer

Entyvio is a brand name for Vedolizumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Vedolizumab

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations